While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...
In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.
DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company ...
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook ...
Medical Device Network on MSN
JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth
Dexcom’s new CEO is eyeing growth in the international market as a key strategy for 2026, fresh off the back of the company ...
DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...
Roxy Horner cut a chic figure as she arrived at swanky restaurant Sale E Pepe in Knightsbridge, London, on Saturday for ...
Wearable makers like Apple, Samsung, Garmin, Google have long chased what might be the holy grail of health tech: ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
9d
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App
Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback